CALGARY, ALBERTA--(CCNMatthews - June 19, 2007) - Stem Cell Therapeutics Corp. (“SCT”) (TSX VENTURE:SSS - News) announced that Dr. Alan Moore, President and CEO, will be presenting today at the BIO VentureForum East conference which is being held at the Marriott Chateau Champlain in Montreal, Quebec from June 18-20, 2007. Dr. Moore will provide an overview to industry executives, potential collaborators, and investors, regarding SCT’s Phase IIa clinical safety study with NTx(TM)-265 in stroke victims as well as outline the company’s future goals and planned clinical programs.
